Cargando…
Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection
Human challenge studies are instrumental for testing cholera vaccines, but these studies use outdated strains and require inpatient facilities. Here, we created next-generation isogenic Ogawa and Inaba O1 V. cholerae challenge strains (ZChol strains) derived from a contemporary Zambian clinical isol...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040834/ https://www.ncbi.nlm.nih.gov/pubmed/35389261 http://dx.doi.org/10.1128/mbio.00539-22 |
_version_ | 1784694417380081664 |
---|---|
author | Fakoya, Bolutife Hullahalli, Karthik Rubin, Daniel H. F. Leitner, Deborah R. Chilengi, Roma Sack, David A. Waldor, Matthew K. |
author_facet | Fakoya, Bolutife Hullahalli, Karthik Rubin, Daniel H. F. Leitner, Deborah R. Chilengi, Roma Sack, David A. Waldor, Matthew K. |
author_sort | Fakoya, Bolutife |
collection | PubMed |
description | Human challenge studies are instrumental for testing cholera vaccines, but these studies use outdated strains and require inpatient facilities. Here, we created next-generation isogenic Ogawa and Inaba O1 V. cholerae challenge strains (ZChol strains) derived from a contemporary Zambian clinical isolate representative of current dominant pandemic V. cholerae. Since the primary mechanism of immune protection against cholera is thought to be antibody responses that limit V. cholerae colonization and not the diarrheagenic actions of cholera toxin, these strains were rendered nontoxigenic. In infant mice, the ZChol strains did not cause diarrhea and proved to accurately gauge reduction in intestinal colonization mediated by effective vaccination. ZChol strains were also valuable as targets for measuring vibriocidal antibody responses. Using barcoded ZChol strains, we discovered that vaccination and passive immunity in the infant mouse model tightens the infection bottleneck without restricting pathogen expansion during intestinal infection. Collectively, our findings suggest that ZChol strains have the potential to enhance the safety, relevance, and scope of future cholera vaccine challenge studies and be valuable reagents for studies of immunity to cholera. |
format | Online Article Text |
id | pubmed-9040834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-90408342022-04-27 Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection Fakoya, Bolutife Hullahalli, Karthik Rubin, Daniel H. F. Leitner, Deborah R. Chilengi, Roma Sack, David A. Waldor, Matthew K. mBio Research Article Human challenge studies are instrumental for testing cholera vaccines, but these studies use outdated strains and require inpatient facilities. Here, we created next-generation isogenic Ogawa and Inaba O1 V. cholerae challenge strains (ZChol strains) derived from a contemporary Zambian clinical isolate representative of current dominant pandemic V. cholerae. Since the primary mechanism of immune protection against cholera is thought to be antibody responses that limit V. cholerae colonization and not the diarrheagenic actions of cholera toxin, these strains were rendered nontoxigenic. In infant mice, the ZChol strains did not cause diarrhea and proved to accurately gauge reduction in intestinal colonization mediated by effective vaccination. ZChol strains were also valuable as targets for measuring vibriocidal antibody responses. Using barcoded ZChol strains, we discovered that vaccination and passive immunity in the infant mouse model tightens the infection bottleneck without restricting pathogen expansion during intestinal infection. Collectively, our findings suggest that ZChol strains have the potential to enhance the safety, relevance, and scope of future cholera vaccine challenge studies and be valuable reagents for studies of immunity to cholera. American Society for Microbiology 2022-04-07 /pmc/articles/PMC9040834/ /pubmed/35389261 http://dx.doi.org/10.1128/mbio.00539-22 Text en Copyright © 2022 Fakoya et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Fakoya, Bolutife Hullahalli, Karthik Rubin, Daniel H. F. Leitner, Deborah R. Chilengi, Roma Sack, David A. Waldor, Matthew K. Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection |
title | Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection |
title_full | Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection |
title_fullStr | Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection |
title_full_unstemmed | Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection |
title_short | Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection |
title_sort | nontoxigenic vibrio cholerae challenge strains for evaluating vaccine efficacy and inferring mechanisms of protection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040834/ https://www.ncbi.nlm.nih.gov/pubmed/35389261 http://dx.doi.org/10.1128/mbio.00539-22 |
work_keys_str_mv | AT fakoyabolutife nontoxigenicvibriocholeraechallengestrainsforevaluatingvaccineefficacyandinferringmechanismsofprotection AT hullahallikarthik nontoxigenicvibriocholeraechallengestrainsforevaluatingvaccineefficacyandinferringmechanismsofprotection AT rubindanielhf nontoxigenicvibriocholeraechallengestrainsforevaluatingvaccineefficacyandinferringmechanismsofprotection AT leitnerdeborahr nontoxigenicvibriocholeraechallengestrainsforevaluatingvaccineefficacyandinferringmechanismsofprotection AT chilengiroma nontoxigenicvibriocholeraechallengestrainsforevaluatingvaccineefficacyandinferringmechanismsofprotection AT sackdavida nontoxigenicvibriocholeraechallengestrainsforevaluatingvaccineefficacyandinferringmechanismsofprotection AT waldormatthewk nontoxigenicvibriocholeraechallengestrainsforevaluatingvaccineefficacyandinferringmechanismsofprotection |